Sentences with phrase «new schizophrenia treatments»

«New schizophrenia treatments may be effective for subgroup of patients.»

Not exact matches

In addition to the new work's potential for RS, there is speculation that it could pave the way to treatments for other neurological disorders, such as learning disabilities, schizophrenia, autism and newborn encephalopathy as well as some mental retardation that has also been linked to the Mecp2 gene.

Parsing these complex symptoms could help inform new treatment approaches for schizophrenia and other disorders.

Unlike «big data» genetic studies, which have loosely linked hundreds of genetic changes to schizophrenia but can not explain varying symptoms, the new study revealed distinct disease versions that may affect large slices of patients and enable precision treatment design, say the authors.

Advances in our understanding of the biological pathways and mechanisms involved will help uncover new targets for treatment, which could one day translate into better, more personalised care for people living with schizophrenia.»

Professor Sir Mike Owen, who leads the MRC Centre at Cardiff University, said: «These findings are another important step on the long road to new treatments for schizophrenia and will be crucial for identifying potential new drugs, which will become an increasing focus of our work in the coming years.»

But a drug that blocks the rush of noradrenaline through your body can boost your confidence, and may also lead to new treatments for schizophrenia and obsessive compulsive disorder.

Future studies about romantic attachment will focus on using the findings from research such as Young's and Diamond's to develop new treatments for grief associated with partner separation or loss and for disorders that involve social deficits, such as schizophrenia and autism.

The discovery may pave the way for new treatments for autism and schizophrenia.

These findings have provided a new target for schizophrenia treatment.

The discovery of specialist stem cells responsible for our most advanced cognition could pave the way for new treatments for autism and schizophrenia

Published May 4, 2015, in Nature Neuroscience, the new findings may eventually lead to treatment strategies targeted for the underlying causes of schizophrenia and related disorders, said the study's corresponding author Scott Soderling, an associate professor of cell biology and neurobiology in the Duke School of Medicine.

It's possible that one day, a new treatment for schizophrenia could be developed based on these findings that would target an underlying cause of the disease, instead of just the symptoms, as current treatments do, the researchers said.

Researchers randomly selected 801 veterans undergoing treatment for schizophrenia at Veterans Health Administration medical centers in California, New York, Louisiana and Texas.

Now, by dampening the activity of a small group of neurons deep within the mouse brain, researchers have produced cognitive deficits similar to those found in those with schizophrenia, a discovery that they say could potentially lead to new treatments for the disorder, which affects roughly 24 million people worldwide.

A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments.

But researchers have identified a promising new approach that may revolutionize the study and treatment of conditions such as schizophrenia, autism and bipolar disorder.

In addition, she said, the data suggest new avenues of treatment for disorders that have social behavior deficits, from autism to schizophrenia or dementia.

The discovery paves the way for new treatments and hints at the cause of more common hallucinations, such as those associated with schizophrenia.

«Advances on this subject bring new perspectives for the treatment and diagnosis of schizophrenia,» Rehen says.

The results could lead to meaningful new treatments not only for schizophrenia but also for bipolar disorder and multiple sclerosis.

Antipsychotic medications, a mainstay of treatment for schizophrenia, alleviated some of the animals» symptoms.In the new study, Soderling, postdoctoral researcher Il Hwan Kim, and their team characterized three brain abnormalities in the Arp2 / 3 mice that also appear in people with schizophrenia.

The goal is to use this new understanding of the brain to develop novel and effective treatments for schizophrenia and other disorders of compromised glutamatergic signaling.

If the same circuitry is there, it could mean new treatments for autism and schizophrenia.

This is essential in order for us to understand how cannabis increases the risk of schizophrenia and to develop new treatments for people who have the condition and / or a problem with their cannabis use, both in terms of new medicines and better talking therapies.»

Most recently, they have shown that by pharmacologically restoring NMDAR function in these «schizophrenic» mice, their structural, neurochemical, and cognitive deficits can be reversed, pointing to new strategies for more effective treatments for schizophrenia and potentially other serious mental illnesses.

Researchers here are advancing understanding of autism, addiction and mood disorders, improving the treatment of Parkinson's disease, Alzheimer's disease and schizophrenia, and finding new ways to help children succeed in school.

«The wealth of new findings have the potential to kick - start the development of new treatments in schizophrenia, a process which has stalled for the last 60 years.»

The creative use of neuroimaging and other techniques is helping McLean scientists better diagnose and develop new treatments for a range of conditions including substance use disorders, neuropsychiatric conditions such as schizophrenia, major depression, post-traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), and neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis (ALS).

But new research from James Cook University discovered a potential new use for this way of eating — besides helping you make lean gains, the ketogenic diet could help in the treatment of schizophrenia.

In connection with this goal, Vanda's management team has been working diligently over the past several months with the Food & Drug Administration («FDA») to reevaluate its response to Vanda's New Drug Application («NDA») for iloperidone for the treatment of schizophrenia.

The departure from New York came after treatment for schizophrenia.